Junlong Huang

Title: Junlong Huang: Innovator in Oral Sustained-Release Drug Delivery

Introduction

Junlong Huang is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral drug delivery systems. His innovative approach focuses on enhancing the efficacy of insoluble drugs through advanced formulation techniques.

Latest Patents

Junlong Huang holds a patent for an "Oral sustained-release composition for insoluble drug, and preparation method thereof." This patent discloses a novel oral sustained-release composition that is especially suitable for low-dose insoluble drugs. The composition consists of a sustained-release granule part and a gel skeleton part. The sustained-release granule part includes the insoluble drug, an enteric material, and a strong liquid sorbent. The gel skeleton part is made from a hydrophilic gel skeleton material. The preparation method involves creating a suspension of the insoluble drug and enteric material, which is then sprayed onto the strong liquid sorbent. This innovative system prolongs the release time of the drug while ensuring a simple preparation process, high efficiency, uniform drug mixing, and minimal content loss. Junlong Huang has 1 patent to his name.

Career Highlights

Throughout his career, Junlong Huang has worked with several pharmaceutical companies, including Diqi Pharmaceuticals Co., Ltd. and Guangzhou Diqi Pharmaceuticals Co., Ltd. His experience in these organizations has allowed him to refine his skills in drug formulation and development.

Collaborations

Junlong Huang has collaborated with notable professionals in the field, including Wenwei Liang and Xiaofeng Tan. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Junlong Huang is a distinguished inventor whose work in oral sustained-release drug delivery systems has the potential to significantly impact the pharmaceutical industry. His innovative solutions address the challenges associated with insoluble drugs, paving the way for more effective treatments.